16个老龄化概念的比较分析及其对老龄化叙事的影响:图书计量和内容分析
Na Xiao1, Bo Xia1, Laurie Buys2
1School of Architecture and Built Environment, Faculty of Engineering, Queensland University of Technology, D Block Level 4 401, Gardens Point, Brisbane, 4000, Australia, 610481759056.
JMIR aging
|September 23, 2025
概括
虽然各种老龄化概念旨在改善老年人的福祉,但它们对改变负面老龄化叙述的影响是有限的. 未来的研究应该专注于技术,政策和社会支持,以获得更好的衰老结果.
科学领域:
- 老年学与公共卫生
- 衰老的社会学 衰老的社会学
- 卫生政策和管理卫生政策和管理
背景情况:
- 多种衰老概念 (健康,成功,活跃的衰老) 旨在以积极的方式重新定义衰老.
- 这些概念缺乏明确的定义,导致模两可和混乱.
- 它们对转变负面衰老叙述的实际影响尚不清楚.
研究的目的:
- 对16个衰老概念进行全面的审查和比较分析.
- 检查研究中衰老概念的演变如何影响了围绕衰老的叙事.
- 为了确定全球的研究贡献和合作在衰老的概念研究.
主要方法:
- 使用VosViewer绘制国际协作和期刊网络的图书统计分析.
- 使用AntConc进行内容分析,以比较老化概念的重点,应用,挑战和未来方向.
- 确定关键国家和期刊,这些期刊是老龄化概念研究的核心.
主要成果:
- 所有16个概念都旨在通过多种视角 (健康,社会,精神,技术) 提高老年人的生活质量.
- 确定的挑战包括不平等的医疗保健准入,社会参与障碍和技术采用困难.
- 全球研究贡献揭示了不同衰老概念的不同重点和合作.
结论:
- 当前的老龄化概念对重塑负面刻板印象的影响是有限的.
- 未来的努力必须优先考虑技术进步,政策优化和加强社会支持系统.
- 促进全球合作对于促进老年人福祉的创新和可持续解决方案至关重要.
相关概念视频
The Effect of Aging on Tissues
3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
Aging
612
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
612
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Mitochondria
19.6K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
19.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
229
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
229
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197


